In re Facebook, Inc., IPO Securities & Derivative Litigation

42 F. Supp. 3d 556, 2014 U.S. Dist. LEXIS 119595, 2014 WL 4230456
District Court, S.D. New York·Decided August 26, 2014·No. MDL No. 12-2389·Published·Cited by 7 cases

Opinion

OPINION & ORDER

SWEET, District Judge.

Lead plaintiffs First New York Securities L.L.C., T3 Trading Group, LLC, Avatar Securities, LLC, Philip Goldberg, Steve Jarvis, Atish Gandhi, Colin Suzman, Meredith Bailey, and Faisal Sami (the “Lead Plaintiffs”) have moved for an order compelling defendants the NASDAQ OMX Group, Inc. (“NASDAQ OMX”), the NASDAQ Stock Market LLC (“NASDAQ LLC” and collectively with NASDAQ OMX, “NASDAQ”), NASDAQ OMX’s Chief' Executive Officer Robert Greifeld (“Greifeld”), and NASDAQ OMX’s highest-ranking technology officer Anna M. Ewing (“Ewing,” collectively with Griefeld and NASDAQ, the “Defendants”) to produce certain materials, referred to as the “Phase One Discovery Materials,”1 within thirty (30) days of the Court’s order, or on such schedule as may be otherwise agreed to by the parties.

Based on the conclusions set forth below, Lead Plaintiffs’ motion is denied.

Background and Prior Proceedings

Familiarity with the general background of this case and prior litigation between the parties is assumed and set forth in the December 12, 2013 Opinion (“December 12 Opinion”) and February 14, 2014 Opinion & Order (Dkt. No. 206) (“February 14 Opinion”). In re Facebook, Inc., IPO Securities and Derivative Litigation, 986 F.Supp.2d 428 (S.D.N.Y.2013); Dkt. No. 206. Certain facts and allegations are repeated in part as relevant to the issues presented by the instant motion.

On February 14, 2014, NASDAQ filed a timely notice of appeal from the Court’s December 12 Opinion, which was appeal-able as of right to the extent it denied NASDAQ’s claim of immunity. In January 2014, Lead Plaintiffs asked the Court to require production of documents submitted to the Security and Exchange Commission (“SEC”) during the SECs investigation of NASDAQ’s handling of Facebook, Inc.’s initial public offering and other issues. The Court ruled that “immunity rulings are appealable as of right under the collateral order doctrine and divest the Court of jurisdiction while the appeal is pending.” (February 14 Op. at 4, at 474.)

The instant motion was filed on April 24, 2014 and was marked fully submitted on May 7, 2014.

Applicable Standard

Motions to compel are “entrusted to the sound discretion of the district court.” United States v. Sanders, 211 F.3d 711, 720 (2d Cir.2000); see also In re DG Acquisition Corp., 151 F.3d 75, 79 (2d Cir.1998) (a trial court “enjoys wide discretion [558]*558in its handling of pre-trial discovery”) (citations omitted). This discretion to manage discovery can be limited, however, when an appeal is pending on an issue of immunity.

An appeal of the denial of a qualified immunity is appealable as of right under the collateral order doctrine. Bradley v. Jusino, 04-CV-8411, 2009 WL 1403891, *1 (S.D.N.Y. May 18, 2009). Generally, when an appeal is taken pursuant to the collateral order doctrine, district courts retain their jurisdiction to proceed with trial pending resolution from the court above. Id. (citing City of New York v. Beretta U.S.A. Corp., 234 F.R.D. 46, 50 (E.D.N.Y.2006)).

In the context of qualified immunity, courts have applied a “dual jurisdiction” rule under which an appeal of the denial of qualified immunity divests a district court of jurisdiction to proceed with trial unless the district court certifies the appeal as frivolous. Id.; Beretta, 234 F.R.D. at 51; see also Mitchell v. Forsyth, 472 U.S. 511, 526, 105 S.Ct. 2806, 86 L.Ed.2d 411 (1985) (“Harlow thus recognized an entitlement not to stand trial or face the other burdens of litigation.... The entitlement is an immunity from suit rather than a mere defense to liability; and like an absolute immunity, it is effectively lost if a case is erroneously permitted to go to trial.”) (emphasis added); Behrens v. Pelletier, 516 U.S. 299, 308, 116 S.Ct. 834, 133 L.Ed.2d 773 (1996) (noting that immunity “is meant to give government officials a right, not merely to avoid ‘standing trial,’ but also to avoid the burdens of ‘such pretrial matters as discovery’ ”) (emphasis in original) (citing Mitchell, 472 U.S. at 526, 105 S.Ct. 2806); Locurto v. Safir, 264 F.3d 154, 164 (2d Cir.2001) (denials of immunity can be conclusive “with regard to a defendant’s right to avoid pre-trial discovery”) (emphasis in original). As a general rule, when an appeal of the denial of qualified immunity is under consideration, discovery should not proceed. Harlow v. Fitzgerald, 457 U.S. 800, 818, 102 S.Ct. 2727, 73 L.Ed.2d 396 (1982) (finding that discovery should not proceed until the “threshold immunity question” is resolved); Mitchell, 472 U.S. at 526, 105 S.Ct. 2806 (“even such pretrial matters as discovery are'to be avoided if possible”).

Discussion

Lead Plaintiffs assert that the “divestitüre of jurisdiction” rule is not automatic or a per se rule. (Pis.’ Mem. Supp. Mot. to Compel 8.) They argue that this Court is fully empowered to compel production on the basis that production of the Phase One Discovery Materials will not impose a burden on Defendants and is necessary to prevent undue prejudice to the class, and that the Court is fully empowered to compel production of the Phase One Discovery Materials to promote judicial efficiency. (Pis.’ Mem. Supp. Mot. to Compel 4, 6, 8.) They further assert that district courts retain jurisdiction over collateral matters that do not involve issues on appeal even if the pending appeal is not certified as frivolous. (Pis.’ Reply 3.)

1. Lack Of “Undue Burden” Does Not Overcome the General Rule

Lead Plaintiffs assert that valid claims of immunity only protect parties from “unnecessary and burdensome discovery or trial proceedings” and only seek to protect litigants asserting immunity from “broad-reaching discovery.” (Pis.’ Mem. Supp. Mot. to Compel 4 (citing Coollick v. Hughes, 699 F.3d 211, 219 (2d Cir.2012) (quoting Crawford-El v. Britton, 523 U.S. 574, 598, 118 S.Ct. 1584, 140 L.Ed.2d 759 (1998)), Harlow, 457 U.S. at 818, 102 S.Ct. 2727, and Mitchell, 472 U.S. at 526, 105 [559]*559S.Ct. 2806).) Lead Plaintiffs further argue that when the production requested by a plaintiff is neither “burdensome” nor “unnecessary,” the concerns underpinning Crawford-El v. Britton, 523 U.S. 574, 118 S.Ct. 1584, 140 L.Ed.2d 759 (1998), Harlow, and Mitchell are not implicated. (Pis.’ Mem. Supp. Mot. to Compel 4.)

However, the right at issue on an immunity appeal is the right to be immune from being litigated against, rather than liability on a claim. See Mitchell, 472 U.S. at 526, 105 S.Ct. 2806;

Free access — add to your briefcase to read the full text and ask questions with AI

In re Facebook, Inc., IPO Securities & Derivative Litigation, 42 F. Supp. 3d 556, 2014 U.S. Dist. LEXIS 119595, 2014 WL 4230456 (S.D.N.Y. 2014).

42 F. Supp. 3d 556 (In re Facebook, Inc., IPO Securities & Derivative Litigation) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related